Access the full text.
Sign up today, get DeepDyve free for 14 days.
Robert Phillips, Maria Ardeljan, Seiichi Shimabukuro, Martin Goldman, D. Garbowit, H. Eison, L. Krakoff (1991)
Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension.Journal of the American College of Cardiology, 17 7
M. Hartford, J. Wikstrand, I. Wallentin, S. Ljungman, G. Berglund (1985)
Left ventricular wall stress and systolic function in untreated primary hypertension.Hypertension, 7 1
R. Devereux, J. Drayer, S. Chien, T. Pickering, R. Letcher, J. DeYoung, J. Sealey, J. Laragh (1984)
Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension.The American journal of cardiology, 54 6
R.A. Nishimura, R.S. Schwartz, D.R. Holmes (1993)
Failure of calcium channel blockers to improve ventricular relaxation in humansJ Am Coll Cardiol, 21
G. Merrill, M. Young, S. Dorell, L. Krieger (1982)
Coronary interactions between nifedipine and adenosine in the intact dog heart.European journal of pharmacology, 81 4
R. Schmieder, M. Langenfeld, A. Friedrich, H. Schobel, C. Gatzka, H. Weihprecht (1996)
Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension.Circulation, 94 6
R. Tomanek, P. Palmer, G. Peiffer, K. Schreiber, C. Eastham, M. Marcus (1986)
Morphometry of Canine Coronary Arteries, Arterioles, and Capillaries during Hypertension and Left Ventricular HypertrophyCirculation Research, 58
A. Ganau, R. Devereux, T. Pickering, M. Roman, P. Schnall, S. Santucci, M. Spitzer, J. Laragh (1990)
Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension.Circulation, 81 1
K. Wachtell, J. Rokkedal, J.N. Bella (2001)
Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (the LIFE study)Am J Cardiol, 87
G. Lip, D. Felmeden, F. Li-Saw-Hee, D. Beevers (2000)
Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'?European heart journal, 21 20
F. Fouad, J. Słomiński, R. Tarazi (1984)
Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function.Journal of the American College of Cardiology, 3 6
D. Choi, W. Koch, J. Hunter, H. Rockman (1997)
Mechanism of β-Adrenergic Receptor Desensitization in Cardiac Hypertrophy Is Increased β-Adrenergic Receptor Kinase*The Journal of Biological Chemistry, 272
A. Heagerty, S. Bund, C. Aalkjaer (1988)
EFFECTS OF DRUG TREATMENT ON HUMAN RESISTANCE ARTERIOLE MORPHOLOGY IN ESSENTIAL HYPERTENSION: DIRECT EVIDENCE FOR STRUCTURAL REMODELLING OF RESISTANCE VESSELSThe Lancet, 332
Boris Nunez, C. Lavie, Franz Messerli, R. Schmieder, G. Garavaglia, Mireya Nunez (1994)
Comparison of diastolic left ventricular filling and cardiac dysrhythmias in hypertensive patients with and without isolated septal hypertrophy.The American journal of cardiology, 74 6
Pearlman Es, K. Weber, J. Janicki, G. Pietra, A. Fishman (1982)
Muscle fiber orientation and connective tissue content in the hypertrophied human heart.Laboratory investigation; a journal of technical methods and pathology, 46 2
R. Schmieder, M. Schlaich, A. Klingbeil, P. Martus (1998)
Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 13 3
P. Palatini, M. Penzo, A. Racioppa, Elisa Zugno, Giuseppe Guzzardi, Michele Anaclerio, A. Pessina (1992)
Clinical relevance of nighttime blood pressure and of daytime blood pressure variability.Archives of internal medicine, 152 9
R. Querejeta, N. Varo, B. López, M. Larman, E. Artiñano, J. Etayo, J. Ubago, M. Gutierrez-Stampa, J. Emparanza, M. Gil, I. Monreal, J. Mindán, J. Díez (2000)
Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease.Circulation, 101 14
A. Hinderliter, K. Light, Park Willis (1992)
Racial differences in left ventricular structure in healthy young adults.The American journal of cardiology, 69 14
J. Jalil, C. Doering, J. Janicki, R. Pick, S. Shroff, K. Weber (1989)
Fibrillar Collagen and Myocardial Stiffness in the Intact Hypertrophied Rat Left VentricleCirculation Research, 64
W. Post, M. Larson, R. Myers, M. Galderisi, Daniel Levy (1997)
Heritability of left ventricular mass: the Framingham Heart Study.Hypertension, 30 5
P. Thürmann, P. Kenedi, A. Schmidt, S. Harder, N. Rietbrock (1998)
Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension.Circulation, 98 19
R. Esper, O. Burrieza, J. Cacharrón, G. Fábregues, H. Baglivo (1993)
Left ventricular mass regression and diastolic function improvement in mild and moderate hypertensive patients treated with lisinopril.Cardiology, 83 1-2
B. Schwartzkopff, M. Brehm, M. Mundhenke, B. Strauer (2000)
Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease.Hypertension, 36 2
H. Krumholz, M. Larson, Daniel Levy (1993)
Sex differences in cardiac adaptation to isolated systolic hypertension.The American journal of cardiology, 72 3
M. Muiesan, D. Rizzoni, R. Zulli, S. Calebich, E. Porteri, E. Agabiti-Rosei (1993)
Regression of cardiac hypertrophy and night‐time blood pressure reductionJournal of Hypertension, 11
B. Dahlöf, R. Devereux, U. Faire, F. Fyhrquist, T. Hedner, H. Ibsen, S. Julius, S. Kjeldsen, K. Kristianson, O. Lederballe‐Pedersen, L. Lindholm, M. Nieminen, P. Omvik, S. Oparil, H. Wedel (1997)
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.American journal of hypertension, 10 7 Pt 1
Arnold Katz (1998)
Regression of left ventricular hypertrophy: new hope for dying hearts.Circulation, 98 7
S. Turner, E. Boerwinkle (2000)
Genetics of hypertension, target-organ complications, and response to therapy.Circulation, 102 20 Suppl 4
E. Breisch, F. White, C. Bloor (1984)
Myocardial characteristics of pressure overload hypertrophy. A structural and functional study.Laboratory investigation; a journal of technical methods and pathology, 51 3
B. Dahlöf, R. Devereux, U. Faire (1997)
The Losartan Intervention For Endpoint Reduction (LIFE) in hypertension study: rationale, design, and methodsAm J Hypertens, 10
H. Schunkert, V. Dzau, V. Dzau, Shiow Tang, A. Hirsch, C. Apstein, B. Lorell (1990)
Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation.The Journal of clinical investigation, 86 6
E. Marbán, Y. Koretsune (1990)
Cell calcium, oncogenes, and hypertrophy.Hypertension, 15 6 Pt 1
Daniel Levy, R. Garrison, D. Savage, W. Kannel, W. Castelli (1989)
Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study.Annals of internal medicine, 110 2
K. Wachtell, J. Rokkedal, J. Bella, T. Aalto, B. Dahlöf, G. Smith, M. Roman, H. Ibsen, G. Aurigemma, R. Devereux (2001)
Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.The American journal of cardiology, 87 1
Daniel Levy, K. Anderson, D. Savage, W. Kannel, J. Christiansen, W. Castelli (2020)
Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study.Annals of internal medicine, 108 1
G. Schillaci, P. Verdecchia, G. Reboldi, S. Pede, C. Porcellati (2000)
Subclinical left ventricular dysfunction in systemic hypertension and the role of 24-hour blood pressure.The American journal of cardiology, 86 5
I. Hammond, M. Alderman, R. Devereux, E. Lutas, J. Laragh (1984)
Contrast in cardiac anatomy and function between black and white patients with hypertension.Journal of the National Medical Association, 76 3
P. Armario, R. Rey, P. Sánchez, Montserrat Martín-Baranera, G. Torres, J. Juliá, H. Pardell (1999)
Determinants of left ventricular mass in untreated mildly hypertensive subjects: hospitalet study in mild hypertension.American journal of hypertension, 12 11 Pt 1
E. Nelson, B. McKeon (1993)
The treatment of mild hypertension study.JAMA, 270 24
K. Ishihara, Michael Zile, Masayoshi Nagatsu, Kiyoharu Nakano, Masaaki Tomita, S. Kanazawa, Linda Clamp, G. Defreyte, B. Carabello (1992)
Coronary blood flow after the regression of pressure-overload left ventricular hypertrophy.Circulation research, 71 6
J. Brush, D. Faxon, Sean Salmon, A. Jacobs, T. Ryan (1992)
Abnormal endothelium-dependent coronary vasomotion in hypertensive patients.Journal of the American College of Cardiology, 19 4
N. Farina, C. Johnston, L. Burrell (2000)
Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRsJournal of Hypertension, 18
I. Khatri, J. Gottdiener, A. Notargiacomo, E. Freis (1980)
Effect of therapy on left ventricular function in hypertension.Clinical science, 59 Suppl 6
J.K. Ghali, Y. Liao, B. Simmons (1992)
The prognostic role of left ventricular artery diseaseAnn Intern Med, 117
C. Laviades, N. Varo, Javier Fernández, G. Mayor, María Gil, I. Monreal, Javier Díez (1998)
Abnormalities of the extracellular degradation of collagen type I in essential hypertension.Circulation, 98 6
F. Bauwens, D. Duprez, M. Buyzere, T. Backer, J. Kaufman, J. Hoecke, A. Vermeulen, D. Clement (1991)
Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential hypertension.The American journal of cardiology, 68 9
J. Kostis, B. Davis, J. Cutler, R. Grimm, K. Berge, Cohen Jd, C. Lacy, H. Perry, Blaufox, S. Wassertheil-Smoller, H. Black, E. Schron, Berk Dm, J. Curb, W. Smith, R. Mcdonald, W. Applegate (1997)
Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic HypertensionJAMA, 278
David Harrison, D. Barnes, L. Hiratzka, C. Eastham, Richard Kerber, Melvin Marcus, Gen
Pathophysiology and Natural History the Effect of Cardiac Hypertrophy on the Coronary Collateral Circulation
J. Ghali, Y. Liao, B. Simmons, A. Castañer, G. Cao, R. Cooper (1992)
The Prognostic Role of Left Ventricular Hypertrophy in Patients with or without Coronary Artery DiseaseAnnals of Internal Medicine, 117
R. Devereux (1996)
Regression of left ventricular hypertrophy. How and why?JAMA, 275 19
D. Lund, R. Tomanek (1978)
Myocardial morphology in spontaneously hypertensive and aortic-constricted rats.The American journal of anatomy, 152 2
R. Bonow, J. Udelson (1992)
Left Ventricular Diastolic Dysfunction as a Cause of Congestive Heart FailureAnnals of Internal Medicine, 117
W. Grossman, D. Jones, L. Mclaurin (1975)
Wall stress and patterns of hypertrophy in the human left ventricle.The Journal of clinical investigation, 56 1
K. Weber, C. Brilla (1991)
Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone SystemCirculation, 83
J. Molkentin, Jian-rong Lu, C. Antos, B. Markham, J. Richardson, J. Robbins, S. Grant, E. Olson (1998)
A Calcineurin-Dependent Transcriptional Pathway for Cardiac HypertrophyCell, 93
J. Gottdiener, D. Reda, B. Massie, B. Materson, David Williams, R. Anderson (1997)
Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.Circulation, 95 8
C. Abrahams, J. Janicki, K. Weber (1987)
Myocardial hypertrophy in Macaca fascicularis. Structural remodeling of the collagen matrix.Laboratory investigation; a journal of technical methods and pathology, 56 6
R.A. Phillips, L.R. Krakoff, M. Ardeljan (1994)
Relation of left ventricular mass to insulin resistance and blood pressure in non-obese subjectsJ Am Coll Cardiol, 23
H. Schunkert, V.J. Dzau, S.S. Tang (1990)
Increased rat cardiac angiotensin-converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophyJ Clin Invest, 86
R. Phillips, N. Coplan, L. Krakoff, K. Yeager, R. Ross, R. Gorlin, M. Goldman (1987)
Doppler echocardiography analysis of left ventricular filling in treated hypertensive patientsJournal of the American College of Cardiology, 9
M. Ciulla, R. Paliotti, D. Hess, E. Tjahja, S. Campbell, F. Magrini, K. Weber (1997)
Echocardiographic patterns of myocardial fibrosis in hypertensive patients: endomyocardial biopsy versus ultrasonic tissue characterization.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 10 6
M.J. Koren, D.D. Savage, P.N. Casale (1990)
Changes in left ventricular mass predict risk in essential hypertension [abstract]Circulation, 82
J. Neaton, R. Grimm, R. Prineas, J. Stamler, G. Grandits, P. Elmer, J. Cutler, J. Flack, J. Schoenberger, R. Mcdonald, C. Lewis, P. Liebson (1993)
Treatment of Mild Hypertension Study: Final ResultsJAMA, 270
S. MacMahon, D. Wilcken, G. Macdonald (1986)
The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients.The New England journal of medicine, 314 6
F. Dunn, W. Oigman, K. Sungaard-Riise, F. Messerli, H. Ventura, E. Reisin, E. Frohlich (1983)
Racial differences in cardiac adaptation to essential hypertension determined by echocardiographic indexes.Journal of the American College of Cardiology, 1 5
D. Hernández, J. Lacalzada, E. Salido (2000)
Regression of left ventricular hypertrophy by lisinopril after renal transplantation: Role of ACE gene polymorphismKidney Int, 58
B. Andrén, Lars Lind, Hans Lithell (1999)
The influence of different antihypertensive drugs on left ventricular hypertrophy in a population sample of elderly menJournal of Human Hypertension, 13
J. Houghton, M. Frank, A. Carr, T. Dohlen, L. Prisant (1990)
Relation among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease☆Journal of the American College of Cardiology, 15
J. Neaton, R. Grimm, R. Prineas, J. Stamler, G. Grandits, P. Elmer, J. Cutler, J. Flack, J. Schoenberger, R. Mcdonald (1993)
Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.JAMA, 270 6
I. Franz, R. Ketelhut, U. Behr, U. Tönnesmann (1994)
Time course of reduction in left ventricular mass during long-term antihypertensive therapy.Journal of human hypertension, 8 3
Teri Manolio, Daniel Levy, R. Garrison, William Castelli, W. Kannel (1991)
Relation of alcohol intake to left ventricular mass: The Framingham Study.Journal of the American College of Cardiology, 17 3
R.A. Phillips, J.A. Diamond (2000)
Hypertension
L. Tiret, B. Rigat, S. Visvikis, C. Breda, P. Corvol, F. Cambien, F. Soubrier (1992)
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.American journal of human genetics, 51 1
A. Grandi, A. Venco, F. Barzizza, B. Casadei, E. Marchesi, G. Finardi (1989)
Effect of enalapril on left ventricular mass and performance in essential hypertension.The American journal of cardiology, 63 15
A. Mosterd, R.B. D’Agostino, H. Silbershatz (1999)
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophyN Engl J Med, 340
M. Muiesan, M. Salvetti, D. Rizzoni, M. Castellano, F. Donato, E. Agabiti-Rosei (1995)
Association of change in left ventricular mass with prognosis during long-term antihypertensive treatmentJournal of Hypertension, 13
H. Yamada, B. Fabris, A. Allen, B. Jackson, C. Johnston, F. Mendelsohn (1991)
Localization of angiotensin converting enzyme in rat heart.Circulation research, 68 1
Karl Weber (2000)
Targeting pathological remodeling: concepts of cardioprotection and reparation.Circulation, 102 12
G. Simone, R. Devereux, M. Roman, M. Alderman, J. Laragh (1994)
Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults.Hypertension, 23 5
Sheridan Dj (2000)
Regression of left ventricular hypertrophy: do antihypertensive classes differ?Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 18 3
H. Schelbert, M. Phelps, Sung-Cheng Huang, Herbert Selin, D. Kuhl (1981)
N‐13 Ammonia as an Indicator of Myocardial Blood FlowCirculation, 63
C. Laviades, G. Mayor, J. Díez (1994)
Treatment with lisinopril normalizes serum concentrations of procollagen type III amino-terminal peptide in patients with essential hypertension.American journal of hypertension, 7 1
A. Schussheim, Joseph Diamond, Jeffrey Jhang, Robert Phillips (1998)
Midwall fractional shortening is an independent predictor of left ventricular diastolic dysfunction in asymptomatic patients with systemic hypertension.The American journal of cardiology, 82 9
A. Snider, S. Gidding, A. Rocchini, A. Rosenthal, M. Dick, D. Crowley, J. Peters (1985)
Doppler evaluation of left ventricular diastolic filling in children with systemic hypertension.The American journal of cardiology, 56 15
R.O. Bonow, J.E. Udelson (1992)
Left ventricular diastolic dysfunction as a cause of congestive heart failure: Mechanisms and managementAnn Intern Med, 117
Michael Lim, A. Barkan, Andrew Buda (1992)
Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion.Annals of internal medicine, 117 9
P. Douglas, S. Katz, Ellen Weinberg, Ming-Hui Chen, Sanford Bishop, B. Lorell (1998)
Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload.Journal of the American College of Cardiology, 32 4
C. Furberg, J. Cutler (1989)
Diuretic Agents Versus β‐Blockers Comparison of Effects on Mortality, Stroke, and Coronary EventsHypertension, 13
P. Liebson, G. Grandits, S. Dianzumba, R. Prineas, R. Grimm, J. Neaton, J. Stamler (1995)
Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS).Circulation, 91 3
A. Sierra, A. Coca, J. Paré, M. Sánchez, V. Valls, Alvaro Urbano-Mairquez (1993)
Erythrocyte Ion Fluxes in Essential Hypertensive Patients With Left Ventricular HypertrophyCirculation, 88
S.E. Kjeldsen, B. Dahlöf, R. l. Devereux (2000)
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy; the LIFE studyAm J Hypertens, 13
T. Imamura, Akira Takeshita, K. Yamamoto, S. Hoka, Arthur Moss, Peter Schwartz, Richard Crampton, E. Locati, Gary Roubin, Brian Hutton, Phillip, J., Harris, J. Peter, Fletcher, T. David, Kelly, Ted Adams, F. Yanowitz, A. Fisher, Dougglas, Arnold Nelson, Arthur Hagan, Roger Williams, Gad Keren, R. Megidish, Dora, Berenfeld, Shlomo Laniado, William Shapiro, Fred Moradv (1985)
Heritability of cardiac size: an echocardiographic and electrocardiographic study of monozygotic and dizygotic twins.Circulation, 71 1
D. Clement, M. Buyzere, D. Duprez (1993)
Left ventricular function and regression of left ventricular hypertrophy in essential hypertension.American journal of hypertension, 6 3 Pt 2
N. Luca, G. Rosiello, F. Lamenza, B. Ricciardelli, R. Marchegiano, M. Volpe, C. Marelli, B. Trimarco (1992)
Reversal of cardiac and large artery structural abnormalities induced by long-term antihypertensive treatment with trandolapril.The American journal of cardiology, 70 12
Enrico Agabiti-Rosei, Muiesan Ml (1998)
Left ventricular hypertrophy: how to influence an important risk factor in hypertension.Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 16 1
R.E. Schmieder, M.P. Schnieder, P. Martus (2001)
Reduction of left ventricular hypertrophy (LVH) by antihypertensive therapy: results of a meta-analysis of all double-blind randomized studiesJ Am Coll Cardiol, 37
C. Canby, R. Tomanek (1989)
Role of lowering arterial pressure on maximal coronary flow with and without regression of cardiac hypertrophy.The American journal of physiology, 257 4 Pt 2
J. Gottdiener (1991)
Measuring diastolic function.Journal of the American College of Cardiology, 18 1
R. Nosadini, A. Semplicini, P. Fioretto, L. Lusiani, R. Trevisan, V. Donadon, G. Zanette, G. Nicolosi, V. Dall'aglio, D. Zanuttini, G. Viberti (1991)
Sodium‐Lithium Countertransport and Cardiorenal Abnormalities in Essential HypertensionHypertension, 18
S. Kjeldsen, B. Dahlöf, R. Devereux, S. Julius, U. Faire, F. Fyhrquist, H. Ibsen, K. Kristianson, O. Lederballe‐Pedersen, L. Lindholm, M. Nieminen, P. Omvik, S. Oparil, H. Wedel (2000)
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.American journal of hypertension, 13 8
J. Gottdiener (1999)
Clinical trials of single-drug therapy for the cardiac effects of hypertension.American journal of hypertension, 12 1 Pt 2
M. Bikkina, M. Larson, D. Levy (1993)
Asymptomatic ventricular arrhythmias and mortility risk in subjects withs with left ventricular hypertrophyJournal of the American College of Cardiology, 22
C. Granger, M. Karimeddini, V. Smith, H. Shapiro, A. Katz, A. Riba (1985)
Rapid ventricular filling in left ventricular hypertrophy: I. Physiologic hypertrophy.Journal of the American College of Cardiology, 5 4
B. Dahlöf, R. Devereux, S. Julius, S. Kjeldsen, G. Beevers, U. Faire, F. Fyhrquist, T. Hedner, H. Ibsen, K. Kristianson, O. Lederballe‐Pedersen, L. Lindholm, M. Nieminen, P. Omvik, S. Oparil, H. Wedel (1998)
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.Hypertension, 32 6
R. Fagard, P. Lijnen, J. Staessen, L. Thijs, A. Amery (1994)
Mechanical and other factors relating to left ventricular hypertrophy.Blood pressure. Supplement, 1
P.R. Liebson, G. Grandits, R. Prineas (1993)
Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS)Circulation, 87
S. Sen, R. Tarazi, P. Khairallah, F. Bumpus (1974)
Cardiac Hypertrophy in Spontaneously Hypertensive RatsCirculation Research, 35
R. Phillips, L. Krakoff, A. Dunaif, D. Finegood, R. Gorlin, S. Shimabukuro (1998)
Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects.The Journal of clinical endocrinology and metabolism, 83 12
Bruno Villari, Scott Campbell, Otto Hess, Gerhard Mall, Giuseppe Vassalli, K. Weber, H. Krayenbuehl (1993)
Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease.Journal of the American College of Cardiology, 22 5
M. Marcus, D. Harrison, W. Chilian, S. Koyanagi, T. Inou, R. Tomanek, James Martins, C. Eastham, L. Hiratzka (1987)
Alterations in the coronary circulation in hypertrophied ventricles.Circulation, 75 1 Pt 2
V. Smith, W. White, M. Meeran, M. Karimeddini (1986)
Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension.Journal of the American College of Cardiology, 8 6
S. Cottone, A. Vadalà, M. Vella, E. Nardi, G. Mulè', A. Contorno, R. Riccobene, G. Cerasola (1998)
Changes of plasma endothelin and growth factor levels, and of left ventricular mass, after chronic AT1-receptor blockade in human hypertension.American journal of hypertension, 11 5
R. Soufer, D. Wohlgelernter, N. Vita, Marcos Amuchestegui, H. Sostman, H. Berger, B. Zaret (1985)
Intact systolic left ventricular function in clinical congestive heart failure.The American journal of cardiology, 55 8
E. Frohlich, C. Apstein, A. Chobanian, R. Devereux, H. Dustan, V. Dzau, F. Fauad-Tarazi, M. Horan, M. Marcus, B. Massie, M. Pfeffer, R. Re, E. Roccella, D. Savage, C. Shub (1992)
The heart in hypertension.The New England journal of medicine, 327 14
S. Akhter, C. Milano, K. Shotwell, M. Cho, H. Rockman, R. Lefkowitz, W. Koch (1997)
Transgenic Mice with Cardiac Overexpression of α1B-Adrenergic ReceptorsThe Journal of Biological Chemistry, 272
R. González-fernández, P. Altieri, L. Díaz, P. Rodríguez, J. Fernandez, J. Miranda, J. Báez, D. Cantellops, J. Lugo (1992)
Effects of enalapril on heart failure in hypertensive patients with diastolic dysfunction.American journal of hypertension, 5 7
R. Cooper, B. Simmons, A. Castañer, V. Santhanam, J. Ghali, M. Mar (1990)
Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed.The American journal of cardiology, 65 7
Steven Schulman, James Weiss, Lewis Becker, Sidney Gottlieb, Kathleen Woodruff, M. Weisfeldt, G. Gerstenblith (1990)
The effects of antihypertensive therapy on left ventricular mass in elderly patients.The New England journal of medicine, 322 19
E. Frohlich (1999)
Risk Mechanisms in Hypertensive Heart DiseaseHypertension, 34
E. Jones, R. Devereux, M. O’Grady, J. Schwartz, J. Liu, T. Pickering, M. Roman (1997)
Relation of hemodynamic volume load to arterial and cardiac size.Journal of the American College of Cardiology, 29 6
W. White, P. Schulman, M. Karimeddini, V. Smith (1989)
Regression of left ventricular mass is accompanied by improvement in rapid left ventricular filling following antihypertensive therapy with metoprolol.American heart journal, 117 1
H. Krumholz, M. Larson, Daniel Levy (1995)
Prognosis of left ventricular geometric patterns in the Framingham Heart Study.Journal of the American College of Cardiology, 25 4
M. Vrolix, D. Sionis, J. Piessens, J. Lierde, J. Willems, H. Geest (1991)
Changes in Human Coronary Flow Reserve After Administration of Intracoronary DiltiazemJournal of Cardiovascular Pharmacology, 18
S.A. Akhter, C.A. Milano, K.F. Shotwell (1997)
Transgenic mice with cardiac overexpression of alpha1B-adrenergic receptors. In vivo alpha1-adrenergic receptormediated regulation of beta-adrenergic signalingJ Biol Chem, 272
A. Mosterd, R. D’Agostino, H. Silbershatz, P. Sytkowski, W. Kannel, D. Grobbee, Daniel Levy (1999)
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.The New England journal of medicine, 340 16
G Harshfield, Clarence Grim, Chun Hwang, Daniel Savage, Sandra Anderson (1990)
Genetic and environmental influences on echocardiographically determined left ventricular mass in black twins.American journal of hypertension, 3 7
T. Cottle (1973)
The Life StudyJournal of Contemporary Ethnography, 2
Daniel Levy, M. Salomon, R. D’Agostino, A. Belanger, W. Kannel (1994)
Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy.Circulation, 90 4
F. Sato, S. Isoyama, Tamotsu Takishima (1990)
Normalization of impaired coronary circulation in hypertrophied rat hearts.Hypertension, 16 1
Ali Gharavi, Michael Lipkowitz, Joseph Diamond, Jeffrey Jhang, R. Phillips (1996)
Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension.The American journal of cardiology, 77 15
S.B. Dianzumba, D.J. DiPette, C. Cornman (1986)
Left ventricular filling characteristics in mild untreated hypertensionHypertension, 8
M. Senni, C.M. Tribouilloy, R.J. Rodeheffer (1998)
Congestive heart failure in the communityCirculation, 98
D. Brutsaert, F. Rademakers, S. Sys, T. Gillebert, P. Housmans (1985)
Analysis of relaxation in the evaluation of ventricular function of the heart.Progress in cardiovascular diseases, 28 2
A. Ganau, R. Devereux, M. Roman, G. Simone, T. Pickering, P. Saba, Paolo Vargiu, Isabella Simongini, J. Laragh (1992)
Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension.Journal of the American College of Cardiology, 19 7
G. Parati, G. Pomidossi, F. Albini, D. Malaspina, G. Mancia (1987)
Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension.Journal of hypertension, 5 1
R. Pratt, V. Dzau (1999)
Genomics and hypertension: concepts, potentials, and opportunities.Hypertension, 33 1 Pt 2
G. Simone, R. Devereux, M. Koren, G. Mensah, P. Casale, J. Laragh (1996)
Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension.Circulation, 93 2
W. Terpstra, J. May, A. Smit, P. Graeff, T. Havinga, Enno Veur, F. Schuurman, B. Jong, H. Crijns (1999)
Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trialJournal of Hypertension, 19
W. Motz, B. Strauer (1996)
Improvement of coronary flow reserve after long-term therapy with enalapril.Hypertension, 27 5
J. Bouthier, N. Luca, M. Safar, A. Simon (1985)
Cardiac hypertrophy and arterial distensibility in essential hypertension.American heart journal, 109 6
J. Cruickshank, J. Lewis, V. Moore, C. Dodd (1992)
Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy.Journal of human hypertension, 6 2
J. Dı́ez, C. Laviades, G. Mayor, M. Gil, I. Monreal (1995)
Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.Circulation, 91 5
J.B. Kostis, B.R. Davis, J. Cutler (1997)
Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research GroupJAMA, 278
R. Fagard, J. Staessen, L. Thijs (1997)
Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure.Hypertension, 29 1 Pt 1
B. Trimarco, B. Ricciardelli, N. Luca, A. Simone, A. Cuocolo, M. Galva, G. Picotti, M. Condorelli (1985)
Participation of endogenous catecholamines in the regulation of left ventricular mass in progeny of hypertensive parents.Circulation, 72 1
Rick Nishimura, Robert Schwartz, David Holmes, A. Tajik (1993)
Failure of Calcium Channel Blockers to Improve Ventricular Relaxation in HumansJournal of Diagnostic Medical Sonography, 9
B. Dahlöf, R.B. Devereux, S. Julius (1998)
Characteristics of 9194 patients with left ventricular hypertrophy. The LIFE studyHypertension, 32
M. Senni, C. Tribouilloy, R. Rodeheffer, S. Jacobsen, Jonathan Evans, K. Bailey, M. Redfield (1998)
Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.Circulation, 98 21
C. Laviades, N. Varo, J. Díez (2000)
Transforming Growth Factor &bgr; in Hypertensives With Cardiorenal DamageHypertension: Journal of the American Heart Association, 36
S. Oren, F. Messerli, E. Grossman, G. Garavaglia, E. Frohlich (1991)
Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension.Journal of the American College of Cardiology, 17 5
K. Weber (2000)
Fibrosis and hypertensive heart diseaseCurrent Opinion in Cardiology, 15
M. Sasaki, T. Oki, A. Íuchi, T. Tabata, H. Yamada, K. Manabe, K. Fukuda, M. Abe, S. Ito (1996)
Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studiesJournal of Hypertension, 14
M. Lauer, K. Anderson, D. Lévy (1991)
Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study.Journal of the American College of Cardiology, 18 5
K. Weber, J. Janicki, S. Shroff, R. Pick, Robert Chen, R. Bashey (1988)
Collagen Remodeling of the Pressure‐Overloaded, Hypertrophied Nonhuman Primate MyocardiumCirculation Research, 62
G. Simone, V. Palmieri, M. Koren, G. Mensah, M. Roman, R. Devereux (2001)
Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertensionJournal of Hypertension, 19
A. Yurenev, Helena Dyakonova, Ilja Novikov, Audrey Vitols, Lothar Pahl, Gisela Haynemann, Diter Wallrabe, Renata Tsifkova, Libusha Romanovska, Peter Niderle, Dmitri Tsiskarishvili, Teymuraz Davarashvili, Ketevan Gelovani, Tsial Kochachidze, Andrash Balash (1992)
Management of essential hypertension in patients with different degrees of left ventricular hypertrophy. Multicenter trial.American journal of hypertension, 5 6 Pt 2
R. Zusman, D. Christensen, E. Federman, T. Ruddy, D. Miller, C. Boucher (1989)
Nifedipine, but not propranolol, improves left ventricular systolic and diastolic function in patients with hypertension.The American journal of cardiology, 64 11
G. Harshfield, B. Alpert, E. Willey, G. Somes, J. Murphy, L. Dupaul (1989)
Race and Gender Influence Ambulatory Blood Pressure Patterns of AdolescentsHypertension, 14
P. Verdecchia, C. Porcellati, O. Cuccurullo, C. Cosco (2000)
Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension.Hypertension, 35 2
B. Innes, M. McLaughlin, M. Kapuscinski, H. Jacob, S. Harrap (1998)
Independent genetic susceptibility to cardiac hypertrophy in inherited hypertension.Hypertension, 31 3
B. Strauer (1992)
The Concept of Coronary Flow ReserveJournal of Cardiovascular Pharmacology, 19
E. Picano, G. Pelosi, M. Marzilli, F. Lattanzi, A. Benassi, L. Landini, A. L'Abbate (1990)
In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans.Circulation, 81 1
R. Phillips, M. Goldman, Maria Ardeljan, R. Arora, H. Eison, Yu Buyan, L. Krakoff (1989)
Determinants of abnormal left ventricular filling in early hypertension.Journal of the American College of Cardiology, 14 4
G. Mancia, A. Zanchetti, Enrico Agebiti-Rosei, G. Benemio, R. Cesaris, R. Fogari, A. Pessino, C. Porcellati, A. Salvetti, B. Trimarco (1997)
Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular HypertrophyCirculation, 95
J. Szlachcic, J. Tubau, C. Vollmer, B. Massie (1989)
Effect of diltiazem on left ventricular mass and diastolic filling in mild to moderate hypertension.The American journal of cardiology, 63 3
J. Gottdiener, D. Reda, David Williams, B. Materson, W. Cushman, Robert Anderson (1997)
Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: comparison of six antihypertensive agents.Circulation, 98 2
M. Hartford, J. Wikstrand, I. Wallentin, S. Ljungman, L. Wilhelmsen, G. Berglund (1984)
Diastolic function of the heart in untreated primary hypertension.Hypertension, 6 3
C. Brilla, J. Janicki, K. Weber (1991)
Cardioreparative Effects of Lisinopril in Rats With Genetic Hypertension and Left Ventricular HypertrophyCirculation, 83
G. Cannella, E. Paoletti, S. Barocci, F. Massarino, R. Delfino, G. Ravera, Giovanni Maio, A. Nocera, Pietro Patrone, D. Rolla (1998)
Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy.Kidney international, 54 2
B. Schwartzkopff, W. Motz, S. Knauer, H. Frenzel, B. Strauer (1992)
Morphometric investigation of intramyocardial arterioles in right septal endomyocardial biopsy of patients with arterial hypertension and left ventricular hypertrophy.Journal of cardiovascular pharmacology, 20 Suppl 1
E. Agabiti-Rosei, E. Ambrosioni, Cesare Palùt, M. Muiesan, A. Alberto (1995)
ACE inhibitor ramipril is more effective than the β-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) studyJournal of Hypertension, 13
O. Costerousse, J. Allegrini, Manuel López, Frangois, Alhenc-Gelas (1993)
Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes.The Biochemical journal, 290 ( Pt 1)
B. Dahlöf, K. Pennert, L. Hansson (1992)
Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies.American journal of hypertension, 5 2
Jee Kim, E. Lee, W. Lee, Chang Kim, J. Park, C. Suh (1982)
Echocardiographic Assessment of Cardiac Anatomy and Function in Hypertensive PatientsKorean Circulation Journal, 12
J. Dı́ez, C. Laviades (1997)
Monitoring fibrillar collagen turnover in hypertensive heart disease.Cardiovascular research, 35 2
P. Liebson, G. Grandits, R. Prineas, S. Dianzumba, J. Flack, J. Cutler, R. Grimm, J. Stamler (1993)
Hemodynamic Correlates of the Third Heart Sound During the Evolution of Chronic Heart FailureJournal of Diagnostic Medical Sonography, 9
M. Shahi, S. Thom, N. Poulter, P. Sever, Rodney Foale (1990)
Regression of hypertensive left ventricular hypertrophy and left ventricular diastolic functionThe Lancet, 336
J. Rossen, I. Simonetti, M. Marcus, P. Braun, M. Winniford (1989)
The effect of diltiazem on coronary flow reserve in humans.Circulation, 80 5
P. Verdecchia, G. Schillaci, C. Borgioni, A. Ciucci, R. Gattobigio, I. Zampi, G. Reboldi, C. Porcellati (1998)
Prognostic significance of serial changes in left ventricular mass in essential hypertension.Circulation, 97 1
P. Liebson (1990)
Clinical studies of drug reversal of hypertensive left ventricular hypertrophy.American journal of hypertension, 3 6 Pt 1
C. Delcayre, J. Silvestre, Anne Garnier, Abdeslam Oubenaissa, Stephane Cailmail, Estelle Tatara, Bernard Swynghedauw, V. Robert (2000)
Cardiac aldosterone production and ventricular remodeling.Kidney international, 57 4
R. Schmieder, F. Messerli, G. Garavaglia, B. Núñez (1988)
Dietary salt intake. A determinant of cardiac involvement in essential hypertension.Circulation, 78 4
D. Savage, R. Garrison, W. Kannel, D. Lévy, S. Anderson, J. Stokes, M. Feinleib, W. Castelli (1987)
The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study.Circulation, 75 1 Pt 2
D.G. Harrison, D.H. Barnes, L.F. Hiratzka (1985)
The effect of cardiac hypertrophy on the coronary collateral circulationCirculation, 71
C. Laviades, N. Varo, J. Díez (2000)
Transforming growth factor β in hypertensives with cardiorenai damageHypertension, 36
A. Sato, Y. Suzuki, T. Saruta (1999)
Effects of spironolactone and angiotensin-converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension.Hypertension research : official journal of the Japanese Society of Hypertension, 22 1
K. Rakušan, W. Rochemont, W. Braasch, H. Tschopp, R. Bing (1967)
Capacity of the Terminal Vascular Bed during Normal Growth, in Cardiomegaly, and in Cardiac AtrophyCirculation Research, 21
D. Lévy, R. Garrison, D. Savage, W. Kannel, W. Castelli (1990)
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.The New England journal of medicine, 322 22
G. Simone, R. Devereux, M. Roman, A. Ganau, P. Saba, M. Alderman, J. Laragh (1994)
Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension.Journal of the American College of Cardiology, 23 6
B. Dahlöf, R. Devereux, U. Defaire, F. Fyhrquist, T. Hedner, H. Ibsen, S. Julius, S. Kjeldsen, K. Kristianson, O. Lederballe‐Pedersen, L. Lindholm, M. Nieminen, P. Omvik, S. Oparil, H. Wedel (1997)
H35: Baseline characteristics of the life (Losartan intervention for endpoint reduction) in hypertension studyAmerican Journal of Hypertension, 10
Alberto Cuocolo, Frederick Sax, John Brush, Barry Maron, S. Bacharach, Robert Bonow (1990)
Left ventricular hypertrophy and impaired diastolic filling in essential hypertension. Diastolic mechanisms for systolic dysfunction during exercise.Circulation, 81 3
B. Trimarco, N. Luca, G. Rosiello, B. Ricciardelli, S. Betocchi, P. Filardi, M. Raponi, M. Condorelli (1989)
Improvement of diastolic function after reversal of left ventricular hypertrophy induced by long-term antihypertensive treatment with tertatolol.The American journal of cardiology, 64 12
M. Pahor, J. Guralnik, M. Corti, D. Foley, P. Carbonin, R. Havlik (1995)
Long‐Term Survival and Use of Antihypertensive Medications in Older PersonsJournal of the American Geriatrics Society, 43
B. López, R. Querejeta, N. Varo, Arantxa González, M. Larman, J. Ubago, J. Díez (2001)
Usefulness of Serum Carboxy-Terminal Propeptide of Procollagen Type I in Assessment of the Cardioreparative Ability of Antihypertensive Treatment in Hypertensive PatientsCirculation: Journal of the American Heart Association, 104
Tatiana Kuznetsova, Tatiana Kuznetsova, J. Staessen, J. Wang, Jerzy Gasowski, Yu. Nikitin, A. Ryabikov, R. Fagard (2000)
Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysisJournal of Human Hypertension, 14
P. Ferrari (1998)
Pharmacogenomics: a new approach to individual therapy of hypertension?Current Opinion in Nephrology and Hypertension, 7
P. Verdecchia, G. Schillaci, C. Borgioni, A. Ciucci, M. Battistelli, C. Bartoccini, A. Santucci, C. Santucci, G. Reboldi, C. Porcellati (1995)
Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass.Journal of the American College of Cardiology, 25 4
R. Zusman, Donna Christensen, J. Higgins, C. Boucher (1991)
Nifedipine Improves Left Ventricular Function in Patients with HypertensionJournal of Cardiovascular Pharmacology, 18
A. Hinderliter, K. Light, P. Willis (1992)
Gender differences in left ventricular structure and function in young adults with normal or marginally elevated blood pressure.American journal of hypertension, 5 1
J. Ghali, J. Ghali, Y. Liao, R. Cooper (1998)
Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease.Journal of the American College of Cardiology, 31 7
C. Brilla, R. Funck, H. Rupp (2000)
Lisinopril-Mediated Regression of Myocardial Fibrosis in Patients With Hypertensive Heart DiseaseCirculation: Journal of the American Heart Association, 102
M. Kohno, K. Yokokawa, M. Minami, H. Kano, K. Yasunari, T. Hanehira, J. Yoshikawa (1999)
Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.The American journal of medicine, 106 5
I. Clements, K. Bailey, P. Zachariah (1994)
Effects of exercise and therapy on ventricular emptying and filling in mildly hypertensive patients.American journal of hypertension, 7 8
J. Lewis, J. Lewis, B. Maron, B. Maron (1990)
Diversity of patterns of hypertrophy in patients with systemic hypertension and marked left ventricular wall thickening.The American journal of cardiology, 65 13
G. Andronico, M. Mangano, E. Nardi, G. Mulè', G. Piazza, G. Cerasola (1993)
Insulin-like growth factor 1 and sodium—lithium countertransport in essential hypertension and in hypertensive left ventricular hypertrophyJournal of Hypertension, 11
E. Topol, T. Traill, N. Fortuin (1985)
Hypertensive hypertrophic cardiomyopathy of the elderly.The New England journal of medicine, 312 5
J. Sadoshima, Yuhui Xu, H. Slayter, S. Izumo (1993)
Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitroCell, 75
A. Frattola, G. Parati, C. Cuspidi, F. Albini, G. Mancia (1993)
Prognostic value of 24-hour blood pressure variabilityJournal of Hypertension, 11
E.J. Topol, G.V. Traill, N.J. Fortuin (1985)
Hypertensive cardiomyopathy of the elderlyN Engl J Med, 312
A. Coca, R. Gabriel, M. Figuera, J. López-Sendón, R. Fernández, J. Sagastagoitia, José García, R. Barajas (1999)
The impact of different echocardiographic diagnostic criteria on the prevalence of left ventricular hypertrophy in essential hypertension: the VITAE study. Ventriculo Izquierdo Tension Arterial España.Journal of hypertension, 17 10
P. Casale, R. Devereux, M. Milner, G. Zullo, G. Harshfield, T. Pickering, J. Laragh (1986)
Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men.Annals of internal medicine, 105 2
P. Hoogen, E. Feskens, N. Nagelkerke, A. Menotti, A. Nissinen, D. Kromhout (2000)
The Relation between Blood Pressure and Mortality Due to Coronary Heart Disease among Men in Different Parts of the WorldThe New England Journal of Medicine, 342
L. Burrell, J. Droogh, O. Veld, M. Rockell, N. Farina, C. Johnston (2000)
Antihypertensive and antihypertrophic effects of omapatrilat in SHR.American journal of hypertension, 13 10
D. Savage, J. Drayer, W. Henry, E. Mathews, J. Ware, J. Gardin, E. Cohen, S. Epstein, J. Laragh (1979)
Echocardiographic Assessment of Cardiac Anatomy and Function in Hypertensive SubjectsCirculation, 59
A. Coca, R. Gabriel, M. Figuera (1999)
The impact of different echocardiographic diagnostic criteria on the prevalence of left ventricular hypertrophy in essential hypertension: the VITAE studyJ Hypertens, 17
P. Gosse, D. Sheridan, F. Zannad, O. Dubourg, P. Guéret, Y. Karpov, P. Leeuw, J. Palma-Gámiz, A. Pessina, W. Motz, J. Degaute, C. Chastang (2000)
Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE studyJournal of Hypertension, 18
J. Curb, S. Pressel, J. Cutler, P. Savage, W. Applegate, H. Black, G. Camel, BARRY David, PHILLIP Frost, N. Gonzalez, G. Guthrie, A. Oberman, G. Rutan, A. Adams (1996)
Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.JAMA, 276 23
I. Inouye, B. Massie, D. Loge, N. Topić, D. Silverstein, P. Simpson, J. Tubau (1984)
Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension.The American journal of cardiology, 53 1
A. Menotti, A. Keys, H. Blackburn, D. Kromhout, M. Karvonen, A. Nissinen, J. Pekkanen, S. Punsar, F. Fidanza, S. Giampaoli, F. Seccareccia, R. Buzina, I. Mohaček, S. Nedeljkovič, C. Aravanis, A. Dontas, H. Toshima, M. Lanti (1996)
Comparison of multivariate predictive power of major risk factors for coronary heart diseases in different countries: results from eight nations of the Seven Countries Study, 25-year follow-upJournal of Cardiovascular Risk, 3
B. Lorell, W. Grice, C. Apstein (1989)
Influence of hypertension with minimal hypertrophy on diastolic function during demand ischemia.Hypertension, 13 4
F. Fouad, M. Słomiński, R. Tarazi, J. Gallagher (1983)
Alterations in left ventricular filling with beta-adrenergic blockade.The American journal of cardiology, 51 1
A. Schussheim, J. Diamond, R. Phillips (2001)
Left ventricular midwall function improves with antihypertensive therapy and regression of left ventricular hypertrophy in patients with asymptomatic hypertension.The American journal of cardiology, 87 1
M. Lauer, K. Anderson, D. Levy (1992)
Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham Heart Study.Journal of the American College of Cardiology, 19 1
P. Anderson, S. Bishop, S. Digerness (1989)
Vascular remodeling and improvement of coronary reserve after hydralazine treatment in spontaneously hypertensive rats.Circulation research, 64 6
Sanjay Gandhi, John Powers, Abdel-Mohsen Nomeir, Karen Fowle, D. Kitzman, Kevin Rankin, William Little (2001)
The pathogenesis of acute pulmonary edema associated with hypertension.The New England journal of medicine, 344 1
H. Schunkert, H. Hense, S. Holmer, Monica Stender, S. Perz, U. Keil, B. Lorell, G. Riegger (1994)
Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.The New England journal of medicine, 330 23
M. Koren, R. Devereux, P. Casale, D. Savage, J. Laragh (1991)
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.Annals of internal medicine, 114 5
K. Weber, K. Weber, J. Janicki, J. Janicki, Ruth Pick, Ruth Pick, J. Capasso, J. Capasso, Piero Anversa, Piero Anversa (1990)
Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension.The American journal of cardiology, 65 14
J. Noon, B. Walker, D. Webb, A. Shore, David Holton, Hugh Edwards, Graham Watt (1997)
Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure.The Journal of clinical investigation, 99 8
Not Available (2001)
Literature AbstractsPediatric Nephrology, 16
R. Devereux, T. Pickering, G. Harshfield, H. Kleinert, L. Denby, L. Clark, D. Pregibon, M. Jason, Beat Kleiner, J. Borer, J. Laragh (1983)
Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress.Circulation, 68 3
J. Mayet, M. Shahi, R. Foale, N. Poulter, P. Sever, Simon Thom (1994)
Racial differences in cardiac structure and function in essential hypertensionBMJ, 308
L. Shapiro, W. McKenna (1984)
Left ventricular hypertrophy. Relation of structure to diastolic function in hypertension.British Heart Journal, 51
M. Muiesan, E. Agabiti-Rosei, G. Romanelli, M. Beschi, M. Castellano, G. Alari, D. Rizzoni, G. Muiesan (1991)
Improved left ventricular systolic and diastolic function after regression of cardiac hypertrophy, treatment withdrawal, and redevelopment of hypertension.Journal of cardiovascular pharmacology, 17 Suppl 2
Hypertensive heart disease (HHD) is characterized by left ventricular hypertrophy (LVH), alterations of cardiac function, and coronary flow abnormalities. LVH is an independent cardiovascular risk factor related to cardiovascular complications in patients with hypertension. Therefore, a decrease in left ventricular mass is a therapeutic goal in these patients. The effect of the different antihypertensive agents on LVH regression has been studied in nearly 500 clinical trials. Most studies conclude that there is regression of LVH after significant decrease in blood pressure with most commonly prescribed antihypertensive agents. However, the ability to regress LVH is different between antihypertensive drug classes. ACE inhibitors and calcium channel antagonists are more potent in reducing left ventricular mass than β-blockers, with diuretics falling in the intermediate group. Recent data suggest that angiotensin AT1 receptor antagonists reduce left ventricular mass to a similar extent as ACE inibitors or calcium channel antagonists. Although a large number of studies have established that reversal of LVH decreases the occurrence of adverse cardiovascular events in patients with hypertension, the hypothesis that LVH regression is beneficial has not yet been conclusively proven. On the other hand, the time has come to revisit the current management of HHD simply focused on controlling blood pressure and reducing left ventricular mass. In fact, it is necessary to develop new approaches aimed to repair myocardial structure and protect myocardial perfusion and function and, in doing so, to reduce in a more effective manner, adverse risk associated with HHD. The identification of genes involved in both the process of HHD and the response to therapy may be critical for the development of these new approaches. This article will review briefly the available data on the effects of antihypertensive agents on HHD. In addition, the emerging new concepts on the pharmacology of hypertensive myocardial remodeling and the pharmacogenetic basis of the treatment of HHD will be also considered.
American Journal of Cardiovascular Drugs – Springer Journals
Published: Aug 17, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.